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Context: Hypothalamic obesity, cardiovascular disease (CVD), and relapse/progression have a ma-
jor impact on prognosis in childhood-onset craniopharyngioma (CP). We analyzed nuchal skinfold
thickness (NST) on magnetic resonance imaging performed for follow-up monitoring as a novel
parameter for body composition (BC) and CVD in CP.
Objective: The objective of the study was to identify the association of NST with body mass index
(BMI), waist to height ratio (WHtR), functional capacity, and blood pressure (BP) in CP and controls.
Design: This was a cross-sectional and longitudinal prospective study in CP patients.
Setting: The study was conducted at HIT-Endo, KRANIOPHARYNGEOM 2000/2007.
Patients: Participants included 94 CP patients and 75 controls.
Interventions: There were no interventions.
Main Outcome Measures: Association of NST with BC and BP in 43 CP and 43 controls was measured.
Results: NST correlated with BMI SD score (SDS; r  0.78; P  .001; n  169) and WHtR (r  0.85;
P  .001; n  86) in the total cohort and CP patients (NST-BMI SDS: r  0.77, P  .001, n  94);
NST-WHtR: r  0.835, P  .001, n43) and controls (NST-BMI SDS: r  0.792, P  .001, n  75;
NST-WHtR: r  0.671, P  .001, n  43). In CP, systolic BP correlated with NST (r  0.575, P  .001),
BMI SDS (r  0.434, P  .004), and WHtR (r  0.386, P  .011). Similar results were observed for
diastolic BP in CP. In multivariate analyses, NST had a predictive value for hypertension in post-
pubertal CP and controls (odds ratio 6.98, 95% confidence interval [1.65, 29.5], P  .008). During
a longitudinal follow-up, changes in NST correlated with changes in BMI SDS (P  .001) and WHtR
(P  .01) but not with changes in BP and functional capacity.
Conclusions: Because monitoring of magnetic resonance imaging and BC is essential for follow-up
in CP, NST could serve as a novel and clinically relevant parameter for longitudinal assessment of
BC and CVD risk in CP. (J Clin Endocrinol Metab 101: 4922–4930, 2016)
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Childhood-onset craniopharyngiomas (CPs) are rare in-tracranial embryonal malformations of the sellar re-
gion (1). CPs show low-grade histological malignancy
(World Health Organization grade I) and frequently affect
hypothalamic and pituitary regions and the optic chiasm.
Hypothalamic involvement and/or treatment-related le-
sions to the above structures result in impaired physical
and social functionality (2) that includes severe neuroen-
docrine sequelae, mainly hypothalamic obesity, with ma-
jor negative impact on quality of life in surviving patients
(1–5). CP patients have a 3- to 19-fold higher cardiovas-
cular mortality in comparison with the general popula-
tion; women with CP have an even higher risk (6). The
20-year overall survival is impaired in patients with hy-
pothalamic involvement of CP (2). Accordingly, regular
monitoring by cranial magnetic resonance imaging (MRI)
and assessment of body composition (BC) are essential
parts of follow-up care (7).
Regional fat distribution rather than overall obesity has
been recognized as important to understanding the link
between obesity and cardiovascular disease (CVD). Vis-
ceral adipose tissue (VAT) is recognized as a unique,
pathogenic fat depot, conferring metabolic risk above and
beyond standard anthropometric measures, such as body
mass index (BMI) and waist circumference (8). Individuals
with large amounts of visceral fat are at an increased risk
of insulin resistance, type 2 diabetes, and atherosclerosis
(9, 10). However, VAT accounts for only modest corre-
lations between cardiometabolic risk factors, suggesting
that other mechanisms, or other fat depots, may also con-
tribute to the development of CVD risk factors (8).
Upper-body sc fat, as estimated by neck circumference,
may confer risk above and beyond visceral abdominal fat.
Anatomically, upper-body sc fat is a unique fat depot lo-
cated in a separate compartment compared with VAT.
Systemic free fatty acid concentrations are primarily de-
termined by upper-body sc fat, suggesting that this fat
depot may play an important role in risk factor pathogen-
esis (11). Some studies have indicated that neck circum-
ference may be an independent correlate of metabolic risk
factors above and beyond BMI and waist circumference
(12–15).
We report on nuchal skinfold thickness (NST) as mea-
sured on cranial MRI as a novel parameter for assessment
of BC in long-term survivors of CP and the correlation of
NST with blood pressure (BP) as a risk factor for CVD.
Patients and Methods
Patients
For this study, 94 patients with childhood-onset CP, recruited
in the German CP registry and prospectively evaluated in the
multicenter trials HIT Endo and KRANIOPHARYNGEOM
2000/2007 (clinical trial numbers NCT00258453 and
NCT01272622) were analyzed for height, weight, BMI, and
NST during median long-term follow-up of 5 years (range
0.3–31 y) (16). The histological diagnosis of a CP was confirmed
by reference assessment in all cases. Hypothalamic involvement
of CP was assessed by MRI, computed tomography, and/or mi-
croscopic inspection during surgery. Hypothalamic involvement
was defined as involvement of hypothalamic structures either by
tumor growth into the hypothalamus or displacement of hypo-
thalamic structures by the tumor (16). Seventy-five children and
adolescents with normal findings in MRI served as controls. MRI
was performed on controls for exclusion of intracranial pathol-
ogies, underlying headaches (50%) or unclear weight gain
(50%).
In the subgroups of 43 of the 94 CP patients (46%) and 43 of
the 75 controls (57%), associations between NST and BMI,
waist-to-height ratio (WHtR), caliper-assessed skinfold thick-
ness (abdominal, subscapular, biceps, triceps), and systolic and
diastolic BP as risk factors for CVD could be assessed in cross-
sectional analysis performed at the time of last follow-up visit.
Parameters of BC, BP, functional capacity (Fertigkeitenskala
Münster-Heidelberg [FMH] scores), and their association with
NST could be analyzed during a prospective follow-up. NST,
BMI SD score (SDS) (17), WHtR, FMH scores, and systolic/
diastolic BP were assessed simultaneously in 28 patients at 83
postoperative follow-up visits with yearly intervals. Changes in
parameters () during yearly intervals were calculated (n  55)
and the correlations between NST and BMI SDS, NST and
WHtR, BMI SDS and WHtR, NST and FMH scores, NST
and systolic BP (millimeters of mercury), and NST and
diastolic BP (millimeters of mercury) were analyzed.
The study was approved by the local standing committee on
ethical practice, and written parental and/or patient consent was
obtained in all cases.
Assessment of anthropometric parameters
Four skinfold measurements (triceps, biceps, subscapular,
and abdominal) were taken on the right side of the body by a
Harpenden caliper and recorded to the nearest 0.1 cm. NST was
measured on T1-weighted cranial MRI scans of the midline per-
formed on 1.5 Tesla scanners according to the following stan-
dardized assessment. First, a line was drawn crossing the two
anatomically defined points: basion (anterior margin of the fo-
ramen magnum) and opisthion (posterior margin of the foramen
magnum). The diameter of sc nuchal fat was measured over this
line to the nearest 0.1 cm. NST was measured in triplicate by
three independent persons and the arithmetic mean was used for
analyses (see Figure 1). Interindividual reliability of the used
arithmetic mean of NST was 0.982.
Waist circumference was measured midway between the low-
est rib and the top of the iliac crest at the end of gentle expiration.
Circumferences were measured over the naked skin and noted to
the nearest 0.1 cm. Infants were measured in the supine position.
Height was measured using a stadiometer. The median of three
height measurements is shown as SDS according to the references
of Prader et al (18). Patients were weighed on calibrated me-
chanical or electronic step scales, wearing underwear only. BC
and the degree of obesity were evaluated by calculating the BMI
SDS according to the references of Rolland-Cachera et al (17).
Pubertal stage was assessed according to Tanner stages (19).
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Systolic and diastolic BP was measured in millimeters mercury
and recorded using an automatic sphygmomanometer in seated
position after resting for 15 minutes.
Functional capacity assessment
The German daily life ability scale FMH was used for self-
assessment of functional capacity (20). The FMH measures the
capability for routine actions, with 56 items such as can walk
without aid or earns money. It was normalized with 971 persons
(45.5% female), ages between 0 and 102 years, resulting in age-
dependent percentiles. The average time for answering the FMH
questionnaire was 4.5 minutes in first-time users.
Statistical analyses
Statistical analysis was performed with SPSS 23 for Windows
(IBM Corp) and R version 3.2.5. Groups were compared using
a Student’s t test for normally distributed data, the Mann-Whit-
ney U test for nonnormal data, and Fisher’s exact tests for cat-
egorical variables. The normality assumption was verified
graphically. Correlation was calculated with the Pearson corre-
lation coefficient; difference between two dependent correla-
tions was analyzed using the Williams’s test. In case of longitu-
dinal data, a correlation coefficient for repeated observations
was calculated (21). Univariate and multivariate logistic regres-
sions were applied. A stepwise selection process was used, keep-
ing only variables with P  .05 in the final model. Results of
logistic regression are presented as odds ratios and correspond-
ing 95% confidence intervals. The local significance level was set
to P  .05. Nevertheless, all inferential statistics are intended to
be exploratory (hypotheses generating), not confirmatory, and
are interpreted accordingly. Therefore, no adjustment for mul-
tiple testing was applied.
Results
Ninety-four (55 females, 39 males) of 576 patients (286
females, 290 males) with childhood-onset CP recruited in
the German Childhood Craniopharyngioma Registry
with longitudinal follow-up in the trials HIT Endo and
KRANIOPHARYNGEOM 2000/2007 were included in
our study. A total 482 childhood-onset CP patients were
excluded because one or more of the following inclusion
criteria were not fulfilled: sagittal MRI of sufficient quality
for assessment of NST (Figure 1) and height and weight for
assessment of BMI measured within 3 months before or
after the time point of MRI. Seventy-five children and
adolescents (30 females, 45 males) with normal findings in
MRI fulfilled the above-mentioned inclusion criteria
served as controls. In a cross-sectional study on 43 CP
patients (27 females, 16 males) and 43 controls (23 fe-
males, 20 males), NST could be analyzed in relation to
BMI, WHtR, caliper-assessed skinfold thickness, and sys-
tolic and diastolic BP at the time of last postoperative
follow-up visit (Table 1). In the longitudinal prospective
part of our study, conventional parameters of BC, BP, and
their association with NST could be analyzed in 28 pa-
tients at 83 postoperative follow-up visits with yearly
intervals.
Cross-sectional study on NST, BC, and CVD
Childhood-onset CP patients were older (median age
16.4 y, range 4.0–39.4 y) and presented with higher BMI
SDS (median BMI 2.05 SD, range 4.41 to 15.43 SD)
at the time of our study when compared with controls
(median age 10.2 y, range 2.9–18.4 y; median BMI 0.80
SD, range 2.4 to 12.2 SD) (Table 1). NST correlated
positively with BMI SDS (r  0.78; P  .001; n  169) and
WHtR (r  0.85; P  .001; n  86) in the total cohort and
in the subgroups of CP patients (NST-BMI SDS: r  0.77,
Figure 1. NST was measured on T1-weighted sagittal cranial MRI of
the midline according to the following standardized assessment: first, a
line was drawn crossing the two anatomically defined points: basion
(anterior margin of the foramen magnum, indicated by hatched line
arrow) and opisthion (posterior margin of the foramen magnum,
indicated by solid line arrow). The diameter of sc nuchal fat was
measured over this line to the nearest 0.1 cm. Panel A shows NST in a
CP patient with severe obesity due to hypothalamic involvement
(hypothalamic involvement grade II [2], BMI 8.91 SD). Panel B shows
NST in a CP patient with reduced BMI due to diencephalic syndrome
(hypothalamic involvement grade I [2], BMI 2.63 SD [17]). Panel C
shows NST in a healthy, normal-weight control (BMI 1.82 SD).
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P  .001, n  94); NST-WHtR: r  0.835, P  .001, n 
43) and controls (NST-BMI SDS: r  0.792, P  .001, n 
75; NST-WHtR: r  0.671, P  .001, n  43) (Figure 2).
Comparing these correlations, both NST and BMI SDS
showed high correlation with WHtR in CP patients (Wil-
liams’ test: P  .58).
In the subgroups of 43 CP patients and 43 controls,
associations between NST, WHtR, caliper-assessed skin-
fold thickness (abdominal, subscapular, biceps, triceps),
BMI, and BP could be analyzed (Table 1). Also in the
subgroups, NST correlated with BMI SDS and WHtR in
the 43 CP patients (r  0.808, P  .001; r  0.835, P 
.001) and 43 controls (r  0.813, P  .001; r  0.671, P 
.001) (Figure 3).
Comparing NST with caliper-measured skinfold thick-
ness, subscapular and abdominal skinfold thickness had
highest correlation with NST both in CP patients (sub-
scapular: r  0.802, P  .001; abdominal: r  0.71, P 
.001) and controls (subscapular: r  0.724, P  .001;
abdominal: r  0.730, P  .001) (Supplemental Figure 1).
In 43 CP patients, systolic BP correlated with NST (r 
0.575, P  .001) (Figure 4), BMI SDS (r  0.434, P 
.004), and WHtR (r  0.386, P  .011). Similar results
were observed for diastolic BP in CP patients, showing
that diastolic BP correlated with NST (r  0.565, P 
.001), BMI SDS (r  0.516, P  .001), and WHtR (r 
0.434, P  .004). The correlation between NST and sys-
tolic BP was higher (P  .015) than the correlation be-
tween WHtR and systolic BP, whereas the levels of cor-
relations were similar between NST and systolic BP and
BMI SDS and systolic BP (P  .09). In 43 controls, dia-
stolic BP only correlated with NST (r  0.320, P  .037)
(Figure 4). Correlations between diastolic BP and BMI
SDS and WHtR and between systolic BP and NST, BMI
SDS, and WHtR did not reach statistical significance in
controls.
In multivariate analyses, we analyzed which anthropo-
metric parameter (NST, WHtR, BMI SDS, abdominal,
subscapular, biceps, and triceps skinfold thickness) had
an independent impact on systolic and diastolic BP as a
risk factor for CVD in 43 CP patients and 43 controls.
Systolic and diastolic BP in all CP patients and controls
were classified as hypertensive or normotensive BP ac-
cording to a study on WHtR and elevated BP (22). When
Table 1. Characteristics of Craniopharyngioma Patients and Healthy Controls
Patients Characteristics Craniopharyngioma Normal Controls
P
Value
Total group, n 94 75
Gender, females/males 55/39 30/45 .017
Age at diagnosis, y 8.29 (1.30–21.28) – –
Follow-up time, y 5.03 (0.22–30.90) – –
Hypothalamic
involvement, n
44 (47%) – –
Gross total resection, n 19 (20%)
Age at study, y 16.40 (4.00–39.40) 10.20 (2.86–18.41) .001
BMI at study (SDS) (17) 2.05 (4.41 to 15.43) 0.80 (2.42 to 12.20) .005
Height at study (SDS) (18) 0.46 (4.90 to 4.69) 1.35 (5.54 to 4.66) .053
Nuchal skinfold, cm 0.99 (0.47–2.76) 0.66 (0.34–2.22) .001
Subgroups, n 43 43
Gender, females/males 27/16 23/20 .51
Age at study, y 18.70 (5.67–35.24) 10.50 (3.29–18.41) .001
Pubertal stage (Tanner)
(19)
I: 12; II: 0; III: 2; IV: 29 I: 27; II: 5; III: 2; IV: 9 .001
BMI at study (SDS) (17) 4.22 (1.10 to 15.43) 1.03 (2.41 to 11.97) .001
Height at study (SDS) (18) 0.05 (3.39 to 4.69) 0.55 (3.99 to 4.66) .59
Waist circumference, cm 107.0 (51.0–175.0) 75.0 (50.0–127.0) .001
WHtR 0.59 (0.38–0.93) 0.47 (0.35–0.66) .001
Nuchal skinfold, cm 1.17 (0.52–2.76) 0.73 (0.36–1.76) .001
Skinfolds, cm, abdominal 3.90 (0.22–6.00) 1.50 (0.30–5.30) .001
Subscapular 3.50 (0.19–6.50) 1.20 (0.30–4.80) .001
Biceps 2.50 (0.50–5.90) 1.10 (0.30–2.80) .001
Triceps 3.10 (0.70–6.30) 1.70 (0.30–4.30) .001
RR systolic BP, mm Hg 123 (94–176) 118 (94–153) .043
RR diastolic BP, mm Hg 77 (59–143) 72 (50–106) .005
Characteristics of 94 patients with childhood-onset CP recruited in HIT Endo and KRANIOPHARYNGEOM 2000/2007 and 75 controls, who were
analyzed for NST assessed on MRI, height SDS (18), and BMI SDS (17), and the subgroups of 43 CP patients and 43 controls who could be
analyzed based on complete data sets for NST, BMI SDS (17); WHtR; caliper-measured skinfold thickness (abdominal, subscapular, biceps, triceps);
and systolic and diastolic BP. Shown are median and range if not otherwise specified.
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analyzing the total subgroup of 86, no risk factor for
hypertension could be identified (data not shown).
However, when limiting the analyses to patients in post-
pubertal Tanner (19) stage 4 or greater (n  26 normal
BP, n  11 hypertensive BP), a noticeable increase in
risk of hypertension could be observed in univariate
analyses for NST, BMI SDS, WHtR, triceps, and sub-
scapular skinfold thickness. When entering all anthro-
pometric parameters in a multivariate logistic regres-
sion analysis and performing stepwise selection, only
NST remained in the final model, showing an almost
7-fold increase of risk of hypertension per centimeter
NST (odds ratios 6.98, 95% confidence interval [1.65,
29.5], P  .008). Obviously this analysis is strongly
limited by the small sample size.
Forty-four of 94 CP patients (47%) presented with hy-
pothalamic involvement of CP (Table 1). Hypothalamic
involvement was significantly associated with obesity in
CP. Patients with hypothalamic involvement presented
with higher BMI (median BMI 3.07 SD, range 4.41 to
11.85 SD, P  .06), higher NST (median NST 1.09 cm,
range 0.47–2.76 cm, P  .008), and
higher WHtR (median WHtR 0.65,
range: 0.43–0.91, P  .014), when
compared with CP without hypotha-
lamic involvement (median BMI
1.51 SD, range 1.10 to 15.43
SD; median NST 0.90 cm, range
0.52–2.47 cm; median WHtR 0.56,
range 0.38–0.93).
We also analyzed other sub-
groups of CP with special character-
istics. Nineteen of 94 CP patients
(20%) were treated by radical sur-
gical resection resulting in refer-
ence-confirmed complete tumor re-
moval. After such gross-total
resection patients presented with higher BMI SDS (me-
dian BMI 4.86 SD, range 1.06 to 10.54 SD) and
NST (median 1.22 cm, range 0.55–2.76 cm) when com-
pared with patients after incomplete resection (median
BMI 1.72 SD, range 4.41 to 15.43 SD; median
NST 0.94 cm, range 0.47–2.47 cm) (P  .004; P 
.034).
A subgroup of three patients presented with a BMI less
than 2 SD at the time of diagnosis (2.63 SD, 2.05 SD,
3.00 SD) and a diencephalic syndrome according to pre-
viously published criteria (23). In all patients with dien-
cephalic syndrome, low BMI SDS was associated with low
NST (NST 0.471 at BMI 2.63 SD; NST 0.644 at BMI
2.05 SD; NST 0.616 at BMI 4.41 SD). All patients
increased their BMI to the upper normal range during
follow-up. Longitudinal data on NST development during
follow-up were not available in these patients with dien-
cephalic syndrome.
Six patients (14%), operated exclusively via transsphe-
noidal approach, presented with lower (P  .001) BMI
Figure 2. Correlations between NST as measured on cranial MRI and BMI SDS (17) in 94
patients with childhood-onset craniopharyngioma recruited in HIT Endo and
KRANIOPHARYNGEOM 2000/2007 (A) and 75 controls (B).
Figure 3. Correlations between NST as measured on cranial MRI and BMI SDS (17) (A), NST and WHtR (B), WHtR and BMI SDS (20) (C) in 43
patients with childhood-onset craniopharyngioma (black dots) recruited in HIT Endo and KRANIOPHARYNGEOM 2000/2007 and 43 controls (gray
dots). r  Pearson correlation coefficient.
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SDS (median BMI 0.57 SDS, range 1.10 to 1.31 SDS)
at last visit (median follow-up 4.9 y, range 1.7–10.9 y)
and lower (P  .001) NST (median NST 0.73 cm, range
0.59 – 0.89 cm) when compared with patients (n  36)
treated via transcranial approach (median BMI 5.07
SDS, range 0.53 to 15.43 SDS; median NST 1.32
cm, range 0.52–2.76 cm, median follow-up 10.2 y,
range 0.1–27.6 y). NST was closely correlated with BMI
SDS also in this subgroup of patients treated via a trans-
sphenoidal approach.
Prospective longitudinal study on NST, BC, and
CVD
During longitudinal follow-up, changes in NST were
significantly associated with changes in BMI SDS (r 
0.703; P  .001) and WHtR (r  0.562; P  .01) (Figure
5). However, changes in NST during follow-up were not
associated with changes in systolic and diastolic BP and
functional capacity (FMH scale) as a measure of quality of
life (Figure 5). Correlations between changes in NST and
changes in caliper-measured skinfold thickness did not
reach statistical significance (Supplemental Figure 2), One
patient suffering from severe obesity (BMI 6.0 SDS) was
treated by bariatric surgery (gastric sleeve resection) and
experienced a severe decrease in BMI SDS of 6 SD during
14 months after bariatric surgery, which was associated
with a 1.0-cm reduction of NST.
Discussion
According to the World Health Organization definition,
metabolic syndrome consists of insulin resistance and at
least two other risk factors from high BP, hypertriglycer-
idemia, low high-density lipoprotein cholesterol, in-
creased BMI, and microalbuminuria. Metabolic syn-
drome can cause CVD and onset of type 2 diabetes in
childhood. Children with obesity
have a higher risk of developing met-
abolic syndrome, caused by their
higher amount of fat tissue com-
pared with normal-weight children
(24–26). It is important to differen-
tiate between two types of fat tissue:
VAT (intraabdominal) and sc adi-
pose tissue (27). VAT is an important
risk factor for metabolic syndrome
and has a higher correlation with the
risk of CVD than sc adipose tissue
and total adipose tissue.
MRI of the body is the golden
standard to measure the different ad-
ipose tissue compartments of the
body, but MRI is an expensive
method to perform for this use alone. Several studies have
analyzed the use of anthropometric parameters in predict-
ing the risk of metabolic syndrome and cardiovascular risk
factors. In a study of adults in which the visceral adipose
tissue on MRI was used as the reference model, the waist
circumference had a higher correlation with VAT in com-
parison with BMI, which seemed to be more correlated
with the total adipose tissue (28). A study of adolescents
in which anthropometric parameters were compared with
MRI showed the same results, although the value of the
waist circumference differed among different age groups
(29). A study of Koren at al (30) showed that the BMI
Z-score and the sagittal abdominal diameter, which mea-
sures the abdominal thickness at waist level in supine po-
sition, were both better predictors of visceral adiposity
tissue in adolescents compared with BMI, waist circum-
ference, or waist-to-hip ratio. Although in adults the
waist-to-hip ratio is associated with cardiovascular events
and diabetes, this relationship is less clear in children,
probably due to developmental changes in body fat dis-
tribution during growth (31, 32).
Several studies have documented that the ratio of waist
circumference to height (WHtR) is superior to waist cir-
cumference and BMI to predict cardiovascular risk factors
(33–36). In a study of German adolescents, WHtR corre-
lated strongly with BMI SDS, and both parameters had a
predictive value for the BP (21). A benefit of the WHtR
measurement is that, according to their study, the param-
eter does not need to be adjusted for age: in every age
category, a cut of value of 0.5 can be used. This makes this
parameter usable for comparison in children at different
ages (21, 37).
Preis et al (12) and da Silva et al (38) reported on neck
circumference as a novel measure of cardiometabolic risk.
Preis et al (12) observed that neck circumference was cor-
Figure 4. Correlations between NST as measured on cranial MRI and systolic (A) and diastolic (B)
BP (millimeters of mercury) in 43 patients with childhood-onset craniopharyngioma (black dots)
recruited in HIT Endo and KRANIOPHARYNGEOM 2000/2007 and 43 controls (gray dots). r 
Pearson correlation coefficient.
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related with VAT and BMI. After further adjustment for
VAT, they found that neck circumference was positively
associated with systolic and diastolic BP and other risk
factors for CVD. As a limitation of their study, the authors
stated that neck circumference serves only as a proxy for
upper-body sc fat without radiographic quantification of
this fat depot (12).
Prognosis and morbidity in long-term survivors of CP
are frequently impaired by hypothalamic obesity due to
tumor and/or treatment related hypothalamic lesions and
high relapse and recurrence rates (1–5). CP patients have
a 3- to 19-fold higher cardiovascular mortality in com-
parison with the general population (6). Accordingly, reg-
ular monitoring by cranial MRI and assessment of BC are
essential parts of their follow-up care (3, 39). Despite sev-
eral studies on the causes of the hypothalamic obesity and
many therapeutic approaches, no effective therapeutic
strategy for treating hypothalamic obesity has been found
thus far.
In our study, cranial MRI performed during follow-up
monitoring was used to measure and analyze NST as a
novel parameter for assessment of BC. The associations
between NST and other parameters of BC (skinfold thick-
ness, BMI, WHtR) and BP as cardiometabolic risk factors
were analyzed in long-term survivors of CP and controls.
In cross-sectional analyses, NST correlated with BC at the
last follow-up visit and NST was strongly associated with
WHtR as a parameter of VAT. Patients with hypothalamic
involvement presented with higher NST. However, ranges
of NST showed a large overlap when compared between
patients with and without hypothalamic involvement, in-
dicating that BC might be a more specific indicator of
hypothalamic obesity than hypothalamic imaging. We
also found that NST independently contributed to hyper-
tension as a cardiometabolic risk factor in postpubertal
ages. The high predictive value of NST for BC and diastolic
BP as CVD risk factor when compared with conventional
parameters was also confirmed in controls. However, for
systolic BP, this could not be confirmed in controls, which
might be related to the different BMI distribution in CP vs
controls.
In longitudinal analyses, the strong association be-
tween changes in NST and changes in BMI SDS and WHtR
could be confirmed. On the other hand, changes in NST
were not correlated significantly with changes in BP, cal-
iper-measured skinfold thickness, and functional capac-
ity. We speculate that this could be explained due to short
12-month intervals of measurement not appropriate for
the development of clinical relevant changes in functional
capacity and BP.
Recent research has focused extensively on BC and
CVD risk. Emphasis has been placed on whether an indi-
vidual has an upper-body or lower-body fat distribution
and what proportion of fat is stored in visceral vs sc fat
depots. Typically, central obesity, particularly high levels
of upper-body visceral fat, is associated with adverse met-
abolic outcomes such as insulin resistance, diabetes, hy-
pertension, and elevated triglycerides, whereas individu-
als with lower-body obesity tend to have lower levels of
these adverse metabolic outcomes (40). Our study sup-
ports the concept that NST could serve as a standardized
and easily measurable proxy of body composition and
presumably upper-body sc fat, which has been reported as
a novel, discrete, and pathogenic fat depot. Furthermore,
our study supports previous reports (2, 3) that hypotha-
lamic involvement has major impact on the development
of obesity in long-term survivors of childhood-onset CP.
Figure 5. NST, BMI SDS (17), WHtR, systolic/diastolic BP, and
functional capacity were assessed simultaneously in 28 patients at 83
postoperative follow-up visits with yearly intervals. Changes in
parameters of BC, BP, and functional capacity () during longitudinal
follow-up at yearly intervals were calculated (n  55). Depicted are the
correlations between NST and BMI SDS (A), NST and WHtR (B),
BMI SDS and WHtR (C), NST and systolic BP (millimeters of
mercury) (D), NST and diastolic BP (millimeters of mercury) (E), and
NST and FMH percentile (ability scale FMH) (F). o,  between visits 1
and 2; ‚,  between visit 2 and 3; r, Pearson correlation coefficient; ,
between visit 3 and 4; ,  between visits 4 and 5; x,  between visits
5 and 6.
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Strengths and limitations
Our pilot study adds to the current literature on obesity
by showing for the first time that NST is correlated with
BC (BMI SDS, WHtR). NST is easily measurable based on
the reported standardized procedure with high interindi-
vidual reliability of assessment. We were able to compare
NST with parameters for BC in a large, well-defined co-
hort of CP patients. One of the limitations of our study is
that, due to the frequency of existing eating disorders in
our cohort of CP patients, fasting blood samples for the
assessment of other risk factors for CVD such as lipids
were not available in these patients. Other measures of
visceral adiposity (ie, abdominal MRI, dual energy X-ray
absorptiometry, impedance studies) as well as normative
data, for example by age, sex, and ethnicity, and neuro-
psychological and lipid status could not be analyzed in our
pilot study but will be part of the study protocol of the next
prospective trial performed in the German Craniophar-
yngioma Registry.
Conclusions
In conclusion, we do not recommend MRI-based assess-
ment of NST as a routine clinical tool in all obese patients.
However, because MRI monitoring is an essential part of
follow-up for early detection of recurrence in CP, mea-
surement of NST could serve as a clinically relevant, easily
determinable, and standardized parameter for the assess-
ment of BC in light of the high association of abdominal
fat mass and its potential predictive value for risk of hy-
pertension and CVD in CP patients. This is particularly
relevant for CP patients with hypothalamic involvement
of CP, who are at special risk for severe obesity and hy-
pertensive BP.
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